Checkpoint Therapeutics, Inc. ("Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, ...

RIPSA interests repurchasedTerm loan facility increased to $450 million with more favorable termsAccess to up to an additional $200 millionLONDON ...

His areas of experience include handling complex quality control operations, regulatory compliance, and leadership of large ...

Discover Lantern Pharma's transformative 2024 journey in precision oncology with AI breakthroughs, global trial expansions, and key clinical milestones ...